Research predicts 2029 small molecule oncology market leaders
With over $7 billion sales predicted by 2029, AstraZeneca’s Tagrisso is set to lead the lung cancer small molecule treatment market, according to GlobalData.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
